Qiru Su
Chinese Center for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Qiru Su.
PLOS ONE | 2013
Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Background The objectives of the survey were to identify the level of influenza vaccination coverage in China in three influenza seasons 2009/10 to 2011/12, and to find out potential predictors for seasonal influenza vaccination. Methods In September and October 2011, representative urban household telephone surveys were conducted in five provinces in China with a response rate of 6%. Four target groups were defined for analysis: 1) children ≤5 years old; 2) elderly persons aged ≥60 years old; 3) health care workers (persons working in the medical field) and 4) chronically ill persons. Results The overall mean vaccination rate was 9.0%. Among the four target groups, the rate of vaccination of children aged ≤5 years old (mean = 26%) was highest and the rate of elderly people aged ≥60 years old (mean = 7.4%) was the lowest, while the rates of persons who suffer from a chronic illness (mean = 9.4%) and health care workers (9.5%) were similar. A subsidy for influenza vaccination, age group, health care workers, suffering from a chronic illness and living in Eastern China were independent significant predictors for influenza vaccination. Conclusions The seasonal influenza vaccination coverage rates among urban populations in selected cities and provinces in China were far below previously reported rates in developed countries. Influenza vaccination coverage rates differed widely between different target groups and provinces in China. Subsidy policy might have a positive effect on influenza vaccination rate, but further cost-effectiveness studies, as well as the vaccination rate associated factors studies are still needed to inform strategies to increase coverage.
PLOS ONE | 2013
Lei Zhou; Sujian Situ; Ting Huang; Shixiong Hu; Wang X; Xiaoping Zhu; Lidong Gao; Zhong Li; Ao Feng; Hui Jin; Shiyuan Wang; Qiru Su; Zhen Xu; Zijian Feng
Background Influenza-related hospitalizations impose a considerable economic and social burden. This study aimed to better understand the economic burden of influenza-related hospitalizations among patients in China in different age and risk categories. Methods Laboratory-confirmed influenza-related hospitalizations between December 2009 and June 2011 from three hospitals participating in the Chinese Severe Acute Respiratory Infections (SARI) sentinel surveillance system were included in this study. Hospital billing data were collected from each hospital’s Hospital Information System (HIS) and divided into five cost categories. Demographic and clinical information was collected from medical records. Mean (range) and median (interquartile range [IQR]) costs were calculated and compared among children (≤15 years), adults (16–64 years) and elderly (≥65 years) groups. Factors influencing cost were analyzed. Results A total of 106 laboratory-confirmed influenza-related hospitalizations were identified, 60% of which were children. The mean (range) direct medical cost was
BMC Infectious Diseases | 2015
Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
1,797 (
International Journal of Epidemiology | 2016
Wen-Zhou Yu; Dawei Liu; Jingshan Zheng; Yanmin Liu; Zhijie An; Lance Rodewald; Guomin Zhang; Qiru Su; Keli Li; Disha Xu; Fuzhen Wang; Ping Yuan; Wei Xia; Gui-Jun Ning; Hui Zheng; Yaozhu Chu; Jian Cui; Mengjuan Duan; Lixin Hao; Yuqing Zhou; Zhenhua Wu; Xuan Zhang; Fuqiang Cui; Li Li; Huaqing Wang
80–
PLOS ONE | 2015
Xiang Zheng; Ningjing Zhang; Xiaoshu Zhang; Lixin Hao; Qiru Su; Haijun Wang; Kongyan Meng; Binglin Zhang; Jianfeng Liu; Huaqing Wang; Huiming Luo; Li Li; Hui Li; Chao Ma
27,545) for all hospitalizations, and the median (IQR) direct medical cost was
PLOS ONE | 2014
Hai-Bo Wang; Gang Fang; Wen-Zhou Yu; Fei Du; Chun-Xiang Fan; Qinglian Liu; Lixin Hao; Yu Liu; Jing-Shan Zheng; Zhi-Ying Qin; Wei Xia; Shi-Yue Zhang; Zun-Dong Yin; Qiong Jing; Yan-Xia Zhang; Rong-Na Huang; Ru-Pei Yang; Wenbin Tong; Qi Qi; Xu-Jing Guan; Yu-Lin Jing; Qian-Li Ma; Jin Wang; Xiaozhen Ma; Na Chen; Hong-Ru Zheng; Yin-Qiao Li; Chao Ma; Qiru Su; Kathleen H. Reilly
231 (
PLOS Medicine | 2017
Sheng Li; Chao Ma; Lixin Hao; Qiru Su; Zhijie An; Fubao Ma; Shuyun Xie; Aiqiang Xu; Yanyang Zhang; ZhengRong Ding; Hui Li; Lisa Cairns; Huaqing Wang; Huiming Luo; Ning Wang; Li Li; Matthew J. Ferrari; Steven Riley
164),
Vaccine | 2016
Chao Ma; Shaohong Yan; Qiru Su; Lixin Hao; Shaopei Tang; Zhijie An; Yulong He; Guangfei Fan; Lance Rodewald; Huaqing Wang
854 (
Pediatrics | 2015
Qiru Su; Yanyang Zhang; Yating Ma; Xiang Zheng; Tongwu Han; Feng Li; Lixin Hao; Chao Ma; Huaqing Wang; Li Li; Huiming Luo
890), and
Vaccine | 2016
Chao Ma; Christopher J. Gregory; Lixin Hao; Kathleen Wannemuehler; Qiru Su; Zhijie An; Linda Quick; Lance Rodewald; Fubao Ma; Rui Yan; Lizhi Song; Yanyang Zhang; Yi Kong; Xiaoshu Zhang; Huaqing Wang; Li Li; Lisa Cairns; Ning Wang; Huiming Luo
2,263 (